Goldman Sachs’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248M | Buy |
2,617,297
+1,575,889
|
|
||||
|
2025
Q1 | $66.1M | Buy |
1,041,408
+763,353
|
|
||||
|
2024
Q4 | $12.9M | Buy |
278,055
+245,166
|
|
||||
|
2024
Q3 | $946K | Sell |
32,889
-93,684
|
|
||||
|
2024
Q2 | $1.83M | Buy |
126,573
+33,793
|
|
||||
|
2024
Q1 | $1.49M | Buy |
92,780
+52,713
|
|
||||
|
2023
Q4 | $797K | Buy |
40,067
+14,668
|
|
||||
|
2023
Q3 | $414K | Buy |
25,399
+3,453
|
|
||||
|
2023
Q2 | $464K | Buy |
21,946
+1,521
|
|
||||
|
2023
Q1 | $410K | Buy |
20,425
+2,577
|
|
||||
|
2022
Q4 | $466K | Sell |
17,848
-18,512
|
|
||||
|
2022
Q3 | $372K | Buy |
36,360
+24,767
|
|
||||
|
2022
Q2 | $49K | Buy |
+11,593
|
|